Educational Background：

PhD in Biochemistry and Molecular Biology from Tsinghua University

China University of Political Science and Law, Master of Law

Visiting Scholar at the University of Notre Dame in the United States

Practice Areas: 

Intellectual Property, Dispute Resolution, Government Regulation and Compliance

Social Position：

• Member of the Pharmaceutical Professional Committee of the China Patent Protection Association
• Member of the Patent Law Committee of the Beijing Bar Association
• Member of the Biomedical Health Committee of Tsinghua Alumni Association
• Director of Tsinghua Health China Alumni Association
• Director of the Intellectual Property Working Committee of the World Federation of Chinese Medicine Societies
• Member of the South South Cooperation Promotion Association of the Ministry of Foreign Affairs
• Internationally renowned legal media CBLJ 2023 “The A-list Legal Elite”
• Invited to teach at Yihong Business School, Tsinghua University of Technology, Beike University, Beijing Administration of Traditional Chinese Medicine, and other institutions
• Invited to give keynote speeches at conferences held by institutions such as Tongfreehand, Yaozhiwang, Yaorongquan, DIA, etc

Work Experience：

Lawyer Tang has been deeply involved in the field of medicine and health, serving clients in various industries such as medicine and biology, medical devices, chemistry, chemical engineering, materials, life sciences, and food. He has a deep understanding of several different industries and can provide targeted and high-quality legal services to clients based on industry characteristics. Lawyer Tang Huadong has represented Roche, Novo Nordisk, AbbVie GSK、 DuPont, Zhengda Tianqing, Qilu Pharmaceutical, Lizhu Pharmaceutical and many other leading domestic and foreign companies in the industry handle various patent applications and litigation affairs, and also provide intellectual property due diligence services for investment institutions such as Sequoia Capital, IDG Capital, Korea KIP Capital, CITIC Securities Investment, and Anlong Fund.

Lawyer Tang leads a team of pharmaceutical professionals whose main members graduated from universities such as Tsinghua University, Peking University, and Peking Union Medical College. They provide professional and efficient technical and legal support for intellectual property protection, investment and financing mergers and acquisitions, listing and restructuring, dispute resolution, and government compliance in the field of pharmaceutical, biological, and health.

Lawyer Tang Huadong is skilled in providing actionable patent strategy layout, patent mining, patent application document writing and review, patent due diligence, patent stability analysis, FTO free implementation legal opinions, patent infringement analysis, patent invalidity challenge, patent infringement litigation, and other aspects from the perspective of client business objectives.

Before joining Zhide, Lawyer Tang Huadong worked for many years at China Patent Agency (Hong Kong) Limited and Beijing King&Wood Mallesons. He was also engaged in patent examination in the China National Intellectual Property Administration and obtained a senior title.

Lawyer Tang graduated from Tsinghua University with a PhD in Biochemistry and Molecular Biology. He also obtained a Master’s degree in Law from China University of Political Science and Law and has experience as an overseas visiting scholar, with over ten years of practical experience in the fields of technology and legal services. Lawyer Tang Huadong is a dual certified lawyer with a lawyer’s license and patent agent qualification, and can work in both Chinese and English languages. Lawyer Tang Huadong is a member of the Pharmaceutical Professional Committee of the China Patent Protection Association, a council member of the Tsinghua Health China Alumni Association, and the first council member of the Intellectual Property Subcommittee of the World Federation of Chinese Medicine Societies.

Representative Performance：

1. Conduct intellectual property due diligence on innovative pharmaceutical and device companies on behalf of industry-leading investment funds and industrial capital;
2. Provide specialized legal advice and FTO analysis on intellectual property for industry-leading A-share and Hong Kong stock IPOs;
3. Provide services such as patent strategy layout, patent invalidation challenge, patent and trade secret litigation for industry-leading pharmaceutical and medical device companies.